News

The proposed federal National Center for Advancing Translational Sciences holds promise for drug development

The basic principle is: say as little as possible in public—and document what is said privately

Manufacturers will share a common access program

Plans to continue expanding in Europe, Asia and Americas

‘Pay and chase’ provisions require manufacturers to pay claims first, then reconcile disputes over charges

A ‘media frenzy’ is ramping up in France and other countries over health authorities’ call for remedial action; meanwhile, US Congress looks at increased review of medical devices

A ‘media frenzy’ is ramping up in France and other countries over health authorities’ call for remedial action; meanwhile, US Congress looks at increased review of medical devices

Proposed rules are sure to generate intense industry feedback

December 2010 and December 2012 dates for adopting GLN and GTIN codes mark steady, if slow, progress

Offers alternative to thermal blankets

New channel data access could overcome the problem of ‘blinded’ pharmaceutical sales data

Purchase of Pieffe Group, combined with new facility launches, brings UPS capacity nearly to 5 million sq.ft. worldwide; more expected in 2012

Analysis combines financial and operational performance, and industry reputation, among manufacturers, distributors and healthcare systems

Latest study validates an observational database as a measure across disparate geographies

Specialty drug market success requires patient-focused and therapy-specific channel and services strategies

E-commerce hub is soliciting more pharma participants to evaluate data-exchange protocols

PCMA study estimates additional $32 billion in added healthcare costs through 2021; coupons ‘lure consumers to switch from generics to expensive brands’

Supplier of active and passive containers lines up regional providers in Asia, Middle East and South America

Production volumes are actually up for some short-supply drugs, indicating a disconnect between manufacturers and the marketplace. Meanwhile, NCPD fights ‘price gouging’ claim

A combination of regulatory processes and business practices are worsening an already-bad drug shortage situation

Taking a market-by-market approach to maximizing value after loss of exclusivity

Unifying a company’s approach to marketing fulfillment activities could provide innovation while delivering cost savings

Pharma marketers become adept at refining coupon and voucher programs, while technology options multiply. Meanwhile payer criticism mounts

Long used in clinical research, cloud computing is now entering commercial and business applications

New HDMA 2011-2012 HDMA Factbook finds gradual growth in IT-based collaborations